Biomarker Analysis and Reporting — Covance (LabCorp)

For us, biomarker analysis and reporting is most valuable when every activity is tied to a clear program question. We begin by understanding the development stage, available inputs, known risks, and the audience for the final deliverables. From there, we define a scope that is scientifically grounded, operationally realistic, and designed to produce information your team can act on.

Our biomarker analysis and reporting capabilities

We approach biomarker analysis and reporting by defining success before the first activity starts. We use early scoping to build a sharper request, review the proposed approach, and agree what a decision-ready result will look like. The goal is to turn precious study samples into reliable measurements that support exposure, response, or biological interpretation. Our project plan explains how the work will produce evidence for whether the samples, method performance, and results justify the next development step, including what will happen if results fall outside expectations. Early alignment on inputs, assumptions, responsibilities, and review gates is often the difference between useful evidence and an expensive activity report. Give our team enough non-confidential context to challenge assumptions, identify dependencies, and recommend a realistic path. Drug development services company providing nonclinical safety assessment, clinical pharmacology, central laboratory, and bioanalytical services. This context helps establish potential fit. Final selection should depend on project-specific evidence: the proposed scientific lead, relevant examples, methods, capacity, quality status, and timeline. Share the program context, available evidence, constraints, and the decision deadline. Resolve material gaps before the scope and quotation are finalized. Agree the methods, responsibilities, dependencies, controls, acceptance criteria, review points, and change process in one executable plan. Run the work against named milestones. Review emerging data and issues at planned gates so our team can adapt without losing traceability. Complete scientific and quality review, explain exceptions and limitations, and connect the final package to an explicit recommendation or next action. This work sits within our Bioanalytical Services capabilities and is coordinated with the wider program context when the scope requires it.

• Sample matrix, collection schedule, volume, stability, and expected concentration.

How we shape the scope

During scoping, we work through the objective, acceptance criteria, dependencies, and potential decision points in plain language. We also identify assumptions that need to be tested before they become schedule or budget problems. The resulting plan defines responsibilities on both sides, shows where reviews will occur, and makes clear how changes in inputs or findings will be handled. This creates a shared operating picture without locking the project into details that should remain flexible.

Working with Covance (LabCorp)

We work as an extension of the program team while maintaining clear ownership of actions and decisions. Regular reviews cover completed work, near-term priorities, risks, and information needed from either side. If new evidence changes the best route, we explain the reason, the available alternatives, and the effect on deliverables or timing. The goal is a transparent engagement in which technical detail supports progress instead of obscuring it.

Deliverables built for the next decision

Outputs are planned for the people who will use them next. At kickoff, we agree on the required files, summaries, documentation, and review process rather than assuming a standard package will fit every program. Our final review connects the deliverables back to the original objective and highlights material observations, limitations within the performed scope, and follow-up questions. This makes the handoff more useful for internal review, partner discussions, and subsequent development planning.

Planning your biomarker analysis and reporting project with Covance (LabCorp)

When you are ready to discuss biomarker analysis and reporting, bring the objective, development context, available inputs, timing needs, and any fixed technical or quality requirements. Our team will translate those details into a proposed scope with clear responsibilities, review gates, deliverables, assumptions, and dependencies so both sides can assess fit before the work begins.